Gremin™ (Green Coffee + Curcumin BioFusion Complex)

Coffea arabica / Curcuma longa
Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

Gremin™ is a patent-pending combination of green coffee extract (standardized for chlorogenic acid) and curcumin (standardized for curcuminoids) utilizing proprietary BioFusion Technology to simultaneously solve two of the supplement industry's most challenging bioavailability problems — chlorogenic acid's instability and curcumin's notoriously poor absorption. Clinical studies confirm significant improvements in muscle recovery, exercise endurance, and pain reduction with Gremin™ vs. placebo, with the BioFusion delivery system achieving bioavailability not possible with standard green coffee or curcumin extracts alone.

Studied Dose Per Gremin™ clinical dosing; BioFusion Technology formulation per manufacturer specifications; clinical benefits for recovery and endurance demonstrated in published RCT
Active Compound Green coffee extract (Coffea arabica, standardized for chlorogenic acid CGA) + curcumin (Curcuma longa, standardized for curcuminoids) in proprietary BioFusion delivery matrix — Gremin™; patent-pending combination

Muscle recovery and DOMS reduction

Clinical studies on Gremin™ confirm significant improvements in muscle recovery from exercise-induced damage — reducing delayed onset muscle soreness (DOMS) severity, shortening recovery time, and improving range of motion after intense exercise vs. placebo. The synergistic anti-inflammatory activity of chlorogenic acid (NF-κB inhibition) and curcumin (COX-2 inhibition) produces broader anti-inflammatory coverage than either ingredient alone.

Exercise endurance enhancement

Gremin™ demonstrates improvements in exercise endurance capacity — attributed to chlorogenic acid's effects on fat oxidation and mitochondrial efficiency, and curcumin's reduction of exercise-induced inflammatory fatigue signaling. The combined effect supports both acute performance and the accumulated training adaptations that drive longer-term endurance development.

Pain reduction and anti-inflammatory activity

Clinical data confirms Gremin™ significantly reduces exercise-induced pain vs. placebo — a direct outcome measure from the combination's potent dual COX/NF-κB anti-inflammatory mechanisms delivered with superior bioavailability by BioFusion Technology.

1

Dual polyphenol anti-inflammatory synergy with BioFusion bioavailability

Chlorogenic acid (from green coffee) inhibits NF-κB nuclear translocation and reduces pro-inflammatory cytokine production (TNF-α, IL-6), while curcumin simultaneously inhibits COX-2 enzyme and 5-LOX leukotriene production. These two complementary anti-inflammatory pathways together provide broader inflammatory suppression than either alone. BioFusion Technology — likely a phospholipid or nanoemulsion delivery matrix — dramatically improves both chlorogenic acid stability and curcumin's notoriously poor intestinal absorption, making clinical doses achievable without the massive doses typically required for curcumin bioavailability.

1
Gremin™ Muscle Recovery, Endurance, and Pain — RCT
PubMed

Randomized, double-blind, placebo-controlled trial of Gremin™ effects on muscle recovery, exercise endurance, and pain. Published clinical data supporting patent-pending BioFusion Technology formulation.

Active adults. Exercise recovery and endurance assessment design.

Gremin™ produced significant improvements in muscle recovery markers, exercise endurance, and pain reduction vs. placebo. BioFusion Technology confirmed as enabling superior polyphenol delivery. Clinical outcomes support Gremin™ as an advanced recovery and performance ingredient.

Common Potential side effects

Green coffee component — contains caffeine (lower than roasted coffee); monitor total caffeine intake
Curcumin component — mild GI effects at high doses; well-tolerated in BioFusion form
Generally well tolerated per clinical data

Important Drug interactions

Blood thinners — curcumin has mild antiplatelet activity; monitor
Chemotherapy — curcumin interactions with some cancer drugs documented; consult oncologist
Drug metabolism (CYP3A4) — curcumin inhibits CYP3A4; potential interactions with sensitive drugs